Home : April 2013 : April 08, 2013 News : scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates

scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates

April 08, 2013

BOSTON, April 8, 2013 /PRNewswire/ -- scPharmaceuticals LLC today announced that it has entered into a strategic partnership and product development agreement with Sensile Medical Holding AG of Zug, Switzerland to develop an innovative new therapeutic option for patients with heart...

http://www.prnewswire.com/news-releases/scpharmaceuticals-llc-announces-strategic-partnership-with-sensile-medical-to-develop-novel-heart-failure-treatment-aimed-to-reduce-readmission-rates-201878311.html
Other Stories